Letter to the Editor: Dupilumab Therapy for Atopic Dermatitis in People Living with HIV

Abstract

Get full access to this article

View all access options for this article.

References

Gooderham

, Hong

, Eshtiaghi

, Papp

: Dupilumab: A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol, 2018; 78(3 Suppl 1):S28–S36.

Ong

, Leung

: Immune dysregulation in atopic dermatitis. Curr Allergy Asthma Rep, 2006; 6:384–389.

Coates

, Leslie

: What's new in HIV dermatology?. F1000Res, 2019; 8:F1000 Faculty Rev-980.

Napolitano

, Scalvenzi

, Fabbrocini

, Cinelli

, Patruno

: Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series. Dermatol Ther, 2019; 32:e13142.

Spekhorst

, Ariens

LFM

, van der Schaft

, et al.: Two-year drug survival of dupilumab in a large cohort of difficult-to-treat adult atopic dermatitis patients compared to cyclosporine A and methotrexate: Results from the BioDay registry. Allergy, 2020; 75:2376–2379.